IL17A and metabolic dysfunction-associated steatohepatitis: The observed expansion of Tregs and the resulting increase in the Treg/Teff ratio did not protect against MASH but correlated with more severe disease in both mice and humans, consistent with a pro-inflammatory shift towards IL-17-producing (TH17-skewed) cells.